dexamethasone/povidone iodine ophthalmic (TAK-640) / Takeda - LARVOL DELTA

"(1) El TOP 35 del #FSTE100 es bienvenido al #ibex35 Les estamos preparando un buen lugar. https://t.co/xtGtVdzxeX" (@AndrewEnderWig4)

Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo (clinicaltrials.gov) - P3; N=221; Terminated; Sponsor: Shire; N=930 ➔ 221; Trial completion date: Jun 2020 ➔ May 2019; Recruiting ➔ Terminated; Trial primary completion date: Jun 2020 ➔ May 2019; Sponsor decision, unrelated to safety

Clinical • Enrollment change • Trial completion date • Trial primary completion date • Trial termination

Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Placebo (clinicaltrials.gov) - P3; N=156; Terminated; Sponsor: Shire; N=284 ➔ 156; Trial completion date: Nov 2019 ➔ May 2019; Recruiting ➔ Terminated; Trial primary completion date: Nov 2019 ➔ May 2019; Sponsor decision, unrelated to safety

Clinical • Enrollment change • Trial completion date • Trial primary completion date • Trial termination